DEFA14A: BlackRock Defends BCAT Against Saba's Takeover Attempt, Urges Shareholders to Vote 'White' Proxy
Proxy Statement
BlackRock is urging shareholders of BlackRock Capital Allocation Term Trust (BCAT) to vote against a takeover attempt by Saba Capital Management, emphasizing BCAT's strong performance and shareholder value initiatives.
Summary
- BlackRock is actively campaigning to protect BlackRock Capital Allocation Term Trust (BCAT) from a takeover attempt by the hedge fund Saba.
- Saba is trying to install its own board nominees, which BlackRock claims is for a quick profit at the expense of long-term shareholders.
- BlackRock highlights BCAT's strong performance, including a 25.1% total shareholder return from January 2023 to May 2024, outperforming its peer median of 13.8%.
- BCAT has significantly narrowed its discount to NAV from 17.7% on 12/31/2022 to 6.6% on 5/31/2024.
- BlackRock emphasizes its discount management program, which includes share buybacks that have resulted in over $13 million in shareholder value.
- The fund intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of each applicable quarter if the fund's common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25.
- Shareholders are urged to vote FOR BlackRock's Class II Board Member Nominees and AGAINST Saba's proposal to terminate the investment management agreement.
- BlackRock urges shareholders to only use the WHITE proxy card and disregard any gold proxy cards from Saba.
Sentiment
Score: 7
Explanation: The document conveys a positive sentiment regarding BCAT's performance and BlackRock's efforts to defend against the takeover attempt, but the presence of an activist investor introduces uncertainty.
Positives
- BCAT has demonstrated strong total shareholder returns, outperforming its peers.
- The discount to NAV has significantly narrowed, increasing shareholder value.
- BlackRock has implemented a discount management program, including share buybacks.
- The fund intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of each applicable quarter if the fund's common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25.
- Distribution growth since 2023 has been 174%.
Negatives
- Saba's takeover attempt creates uncertainty for BCAT's future.
- Saba's previous takeover attempts have allegedly led to underperformance, deeper discounts, and higher fees for shareholders in other funds.
Risks
- If Saba succeeds in its takeover attempt, BCAT's investment strategy and management could change.
- Failure to maintain strong performance could lead to a widening discount to NAV.
- Market fluctuations could impact BCAT's NAV and market price.
Future Outlook
The fund intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of each applicable quarter if the fund's common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25.
Management Comments
- Stephen Minar, Managing Director, Closed-End Funds: 'BlackRock is fighting to protect your fund, but we need your support.'
- Stephen Minar, Managing Director, Closed-End Funds: 'A self-interested hedge fund is attempting to install their own hand-picked Board nominees to BCATs Board. Their goal? A quick profit at the expense of your long-term investment.'
Industry Context
Activist investors like Saba Capital Management frequently target closed-end funds trading at a discount to NAV, seeking to unlock value through various strategies, including board representation and fund restructuring.
Comparison to Industry Standards
- BCAT's total shareholder return of 25.1% significantly outperformed the peer median of 13.8% within the Morningstar Tactical Allocation category.
- The narrowing of BCAT's discount to NAV from 17.7% to 6.6% indicates successful discount management compared to other closed-end funds facing similar challenges.
Stakeholder Impact
- Shareholders are directly impacted by the outcome of the proxy vote.
- Employees of BlackRock could be affected if Saba's takeover attempt is successful.
- The fund's performance impacts its customers and their investment returns.
Next Steps
- Shareholders need to vote on the proxy proposals by June 26.
- BlackRock will continue to advocate for its board nominees and against Saba's proposal.
Key Dates
| Date | Description |
|---|---|
| 12/31/2022 | BCAT's discount to NAV was 17.7%. |
| January 2023 to 5/31/2024 | BCAT's total shareholder return was 25.1%. |
| 5/31/2024 | BCAT's discount to NAV was 6.6%. |
| 6/30/24, 9/30/24, 12/31/24 and 3/31/25 | Quarters for potential repurchase of 2.5% of outstanding common shares if discount exceeds 7.5%. |
| June 26 | BCAT's annual meeting. |
Keywords
BlackRock Capital Allocation Term Trust, BCAT, Saba Capital, Proxy Fight, Shareholder Value, Discount to NAV, Share Buybacks, Investment Management Agreement, Closed-End Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.